NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

JNJ

Johnson & Johnson

Apr 30 • 04:00PM ET

156.31

Dollar change +0.40
Percentage change 0.26	%

Healthcare • Drug Manufacturers - General • USA • NYSE

Peers: MRK PFE NVS AMGN BMY LLY GSK ABT MDT SYK

| Held by: VTI VOO SPY IVV VTV XLV VIG VYM VHT IWD

Scroll to Statements

Index	DJIA, S&P 500	P/E	17.38	EPS (ttm)	9.00	Insider Own	0.13%	Shs Outstand	2.41B	Perf Week	0.60%
Market Cap	376.68B	Forward P/E	14.10	EPS next Y	11.09	Insider Trans	-0.62%	Shs Float	2.41B	Perf Month	-5.75%
Income	21.81B	PEG	3.06	EPS next Q	2.68	Inst Own	72.90%	Short Float	0.87%	Perf Quarter	3.41%
Sales	89.33B	P/S	4.22	EPS this Y	6.28%	Inst Trans	0.64%	Short Ratio	2.17	Perf Half Y	-2.84%
Book/sh	32.47	P/B	4.81	EPS next Y	4.51%	ROA	11.93%	Short Interest	21.02M	Perf Year	6.96%
Cash/sh	16.09	P/C	9.71	EPS next 5Y	5.67%	ROE	29.45%	52W Range	140.68 - 169.99	Perf YTD	8.08%
Dividend Est.	5.13 (3.28%)	P/FCF	18.49	EPS past 5Y	0.55%	ROI	18.73%	52W High	-8.05%	Beta	0.41
Dividend TTM	4.96 (3.17%)	Quick Ratio	1.03	Sales past 5Y	2.03%	Gross Margin	68.24%	52W Low	11.11%	ATR (14)	3.65
Dividend Ex-Date	May 27, 2025	Current Ratio	1.26	EPS Y/Y TTM	29.21%	Oper. Margin	23.83%	RSI (14)	49.87	Volatility	1.66% 2.88%
Employees	138100	Debt/Eq	0.67	Sales Y/Y TTM	-0.37%	Profit Margin	24.41%	Recom	2.15	Target Price	170.40
Option/Short	Yes / Yes	LT Debt/Eq	0.49	EPS Q/Q	238.80%	Payout	84.80%	Rel Volume	0.99	Prev Close	155.91
Sales Surprise	1.55%	EPS Surprise	7.33%	Sales Q/Q	2.39%	Earnings	Apr 15 BMO	Avg Volume	9.70M	Price	156.31
SMA20	1.27%	SMA50	-2.18%	SMA200	-0.49%	Trades		Volume	9,585,564	Change	0.26%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-10-24	Resumed	BofA Securities	Neutral	$166
Nov-15-24	Initiated	Wolfe Research	Outperform	$190
Jul-23-24	Downgrade	Daiwa Securities	Outperform → Neutral	$160 → $150
May-30-24	Resumed	Goldman	Neutral	$160
Apr-18-24	Upgrade	HSBC Securities	Hold → Buy	$170
Dec-13-23	Downgrade	Wells Fargo	Overweight → Equal Weight	$170 → $163
Dec-01-23	Upgrade	UBS	Neutral → Buy	$167 → $180
Oct-05-23	Initiated	RBC Capital Mkts	Outperform	$178
Sep-06-23	Initiated	HSBC Securities	Hold	$175
May-30-23	Resumed	Citigroup	Buy	$185
Mar-29-23	Initiated	UBS	Neutral	$164
Mar-01-23	Initiated	Guggenheim	Neutral	$161
Nov-18-22	Initiated	Credit Suisse	Neutral	$170
Oct-18-22	Initiated	Barclays	Equal Weight	$175
Oct-14-22	Reiterated	BofA Securities	Neutral	$185 → $178
Jun-22-22	Initiated	Daiwa Securities	Outperform
May-23-22	Resumed	SVB Leerink	Outperform	$200
Apr-06-22	Resumed	Morgan Stanley	Equal-Weight	$173
Mar-16-22	Downgrade	Bernstein	Outperform → Mkt Perform	$180 → $183
Mar-02-22	Resumed	BofA Securities	Neutral	$185

Show Previous Ratings

Today 05:02PM	Top Stock Reports for Amazon.com, Johnson & Johnson & Cisco Systems (Zacks)
04:17PM	Johnson & Johnson (JNJ): Jim Cramer Says "They Love the Weak Dollar" - Is This Quiet Giant Back in Favor? (Insider Monkey)
02:28PM	Is Johnson & Johnson (JNJ) the Best Dow Stock for the Next 12 Months? (Insider Monkey)
11:45AM	GSK Q1 Earnings Beat, Sales Lag, Stock Gains on Tariff Reassurance (Zacks)
10:30AM	The Davenport Value & Income Fund Q1 2025 Commentary (Seeking Alpha)
08:29AM	Loading…
08:29AM	Johnson & Johnson receives FDA approval for IMAAVY (nipocalimab-aahu), a new FcRn blocker offering long-lasting disease control in the broadest population of people living with generalized myasthenia gravis (gMG) (PR Newswire)
07:51AM	J&J secures FDA OK for immune drug touted as future blockbuster (BioPharma Dive)
Apr-29-25 08:32PM	Buy Pfizer (PFE) Stock for a Rebound After Crushing Q1 EPS Expectations? (Zacks)
08:07PM	Best Dividend Aristocrats For May 2025 (Seeking Alpha)
03:46PM	SpringWorks: Acquired By Merck KGaA Based On Rare Tumor Targeting Drugs Like OGSIVEO (Seeking Alpha)
11:34AM	Pfizer Q1 Earnings Beat Estimates, Several Headwinds Hurt Sales (Zacks)
11:10AM	4 PFA studies in the spotlight at Heart Rhythm 2025 (MedTech Dive)
08:33AM	Johnson & Johnson (JNJ): Among the Best Long-Term Dividend Stocks to Buy According to Billionaires (Insider Monkey)
06:20AM	Should You Invest in the Fidelity MSCI Health Care Index ETF (FHLC)? (Zacks)
06:20AM	Should iShares Core High Dividend ETF (HDV) Be on Your Investing Radar? (Zacks)
06:25PM	Loading…
Apr-28-25 06:25PM	Stocks Rise in Final Hour of Wall Street Trading: Markets Wrap (Bloomberg)
06:00PM	My 10 Must-Own Dividend Stocks For Your Retirement Portfolio (One Yields 9.65%) (Seeking Alpha)
04:44PM	Johnson & Johnson (JNJ): Among the Most Profitable Blue Chip Stocks to Buy Now (Insider Monkey)
04:27PM	Google Parent Alphabet Leads US High-Grade Issuance Rush (Bloomberg)
04:22PM	Johnson & Johnson to Participate in the Bernsteins 41st Annual Strategic Decisions Conference (Business Wire)
04:05PM	CG Oncology Soars On Its Johnson & Johnson-Rivaling Cancer Drug (Investor's Business Daily)
01:36PM	New data from J&Js bladder cancer drug-device trial strengthens support for NDA (Medical Device Network)
11:20AM	Jim Cramer Says Trump Administration Should Intervene in Johnson & Johnson (JNJ) Legal Issues - 'Where Are Capitalist Instincts Here?' (Insider Monkey)
10:44AM	J&Js Tremfya gains EC marketing authorisation for ulcerative colitis (Pharmaceutical Technology)
10:24AM	CG Oncology Rockets On Its Johnson & Johnson-Rivaling Cancer Drug (Investor's Business Daily)
10:00AM	Insulet Names New CEO, Expects to Top Revenue Projections (Investopedia)
09:45AM	3 Industry Behemoths Are Rewarding Investors With Dividend Bumps (MarketBeat)
09:14AM	GSK to Report First-Quarter Earnings: Is a Beat in Store? (Zacks)
07:28AM	3 Top Big Pharma Stocks Investing Over $100 Billion in the U.S. (MarketBeat)
06:20AM	Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)? (Zacks)
11:40PM	Loading…
Apr-27-25 11:40PM	Why AbbVie's Stock Is A Strong Buy After Q1 2025 Results (Seeking Alpha)
04:01PM	Jim Cramer Says You Should Buy Johnson & Johnson (JNJ), Thinks Talc Problems 'Behind It' (Insider Monkey)
Apr-26-25 02:00PM	Johnson & Johnson's TAR-200 monotherapy achieves high disease-free survival of more than 80 percent in BCG-unresponsive, high-risk papillary NMIBC (PR Newswire)
01:50PM	Johnson & Johnson's TAR-200 monotherapy demonstrates highest complete response rate with sustained clinical benefits in patients with certain types of bladder cancer (PR Newswire)
10:15AM	These 2 Top Dividend Stocks Are Making Moves to Avoid the Impact of Tariffs: Are They Buys? (Motley Fool)
08:59AM	Is Johnson & Johnson (JNJ) the Best Safe Stock to Buy According to Hedge Funds? (Insider Monkey)
Apr-25-25 04:00PM	AbbVie: Q1 Earnings Reinforce Positive Momentum (Seeking Alpha)
01:18PM	AbbVie Beats on Q1 Earnings & Sales, Raises '25 EPS View (Zacks)
09:15AM	Biogen: Is This A Value Trap, Or Is The Great Turnaround Imminent? (Seeking Alpha)
07:29AM	Johnson & Johnson (JNJ) Soared as Markets Favored Defensive Sector (Insider Monkey)
Apr-24-25 02:50PM	TimesSquare U.S. Mid Cap Growth Strategy Q1 2025 Commentary (Seeking Alpha)
09:00AM	Johnson & Johnson (JNJ) is Attracting Investor Attention: Here is What You Should Know (Zacks)
08:34AM	3 Dividend Kings That Have Raised Their Payouts in 2025 (Motley Fool)
07:46AM	Johnson & Johnson Just Proved The Bears Wrong Again (Seeking Alpha)
06:20AM	Is WisdomTree U.S. High Dividend ETF (DHS) a Strong ETF Right Now? (Zacks)
03:51AM	In the Wake of the Trump Tariff Crash: 2 Unparalleled Dividend Stocks to Buy at a Discount Right Now (Motley Fool)
Apr-23-25 09:19PM	Jim Cramer on Johnson & Johnson (JNJ): 'A Good Quarter - Market Finally Cares' (Insider Monkey)
02:58PM	TimesSquare U.S. Small Cap Growth Strategy Q1 2025 Commentary (Seeking Alpha)
09:58AM	2025 Dividend Kings: Weathering Tariff Volatility Better Than The Market (Seeking Alpha)
09:40AM	Why Johnson & Johnson (JNJ) is a Top Value Stock for the Long-Term (Zacks)
08:34AM	Buy, Sell or Hold ABBV Stock? Key Tips Ahead of Q1 Earnings (Zacks)
03:40AM	Magnificent 7 Earnings Out This Week Will Shed Light On Big Tech's Tariff Concerns (Seeking Alpha)
Apr-22-25 10:54PM	JNJ Q1 Earnings: Pipeline Progress and MedTech Execution Drive Guidance Above Expectations (StockStory)
10:01PM	Why Johnson & Johnson, Chevron, And Flowers Foods Are Winners For Passive Income (Benzinga)
09:15AM	ORIC Pharmaceuticals: Multiple Data Releases In 2025 Make It A Must-Watch Biotech (Seeking Alpha)
07:30AM	Two Stocks To Consider During Market Unrest To Provide Income Stability (Seeking Alpha)
05:03AM	Johnson & Johnson (JNJ): Buy, Sell, or Hold Post Q1 Earnings? (StockStory)
Apr-21-25 03:21PM	Intuitive Surgical: Great Company, Wrong Price (Seeking Alpha)
02:00PM	How To Build A $500,000 Dividend Portfolio That Could Yield 18.35% In 20 Years (Seeking Alpha)
10:22AM	Is Johnson & Johnson (JNJ) the Best American Dividend Stock to Buy According to Analysts? (Insider Monkey)
09:36AM	Johnson & Johnson unveils highly anticipated and potential practice-changing data in bladder cancer treatment at AUA (PR Newswire)
08:30AM	Healthcare ETFs Tug of War: Insurers Tumble, Pharma Surges (Zacks)
Apr-20-25 03:14PM	IBM, Parker-Hannifin Among 10 Companies To Announce Dividend Increases In Second Half Of April (Seeking Alpha)
09:20AM	Is Johnson & Johnson (JNJ) the Best Low Volatility Stock to Buy Now? (Insider Monkey)
07:30AM	2 Recession-Proof Stocks to Buy With a Better Credit Rating Than the U.S. Government (Motley Fool)
Apr-19-25 09:01PM	From $50 A Month To $1M Portfolio Investor Shares Top 10 Holdings, Says 'Finally Reached $1M!' Thanks To Relentless Discipline (Benzinga)
11:42AM	Johnson & Johnson (JNJ): Among Value Stocks in Ken Fisher's Portfolio (Insider Monkey)
10:30AM	3 Top Dividend Stocks Yielding Over 3% to Buy With $500 Right Now (Motley Fool)
05:30AM	ClearBridge Small Cap Strategy Q1 2025 Commentary (Seeking Alpha)
01:25AM	Dividend Champion, Contender, And Challenger Highlights: Week Of April 20 (Seeking Alpha)
Apr-18-25 03:08PM	Jim Cramer on Johnson & Johnson (JNJ): Tariff-Proof, Drug-Driven, and Still a Buy (Insider Monkey)
07:00AM	Johnson & Johnson Pivots Its AI Strategy (The Wall Street Journal)
Apr-17-25 10:01PM	How To Put $100 In Your Retirement Fund Each Month With Johnson & Johnson Stock (Benzinga)
10:51AM	Johnson & Johnson (JNJ): Among the Innovative Healthcare Stocks to Watch in 2025 (Insider Monkey)
09:15AM	Pharma Stock Roundup: J&J's Q1 Results, PFE's Obesity Setback (Zacks)
08:10AM	My Dividend Stock Portfolio: New All-Time Dividend Record In March - 100 Holdings With 15 Buys (Seeking Alpha)
08:05AM	Why Most Dividend Retirement Strategies Fail: How To Retire With Dividends (Seeking Alpha)
08:03AM	Here's How You Should Play JNJ Stock After Q1 Earnings Beat (Zacks)
07:05AM	Netflix stock has been nearly unscathed by Trump tariffs. Some think it could be Silicon Valleys version of Johnson & Johnson (Fortune)
06:20AM	Should WisdomTree U.S. High Dividend ETF (DHS) Be on Your Investing Radar? (Zacks)
04:51AM	4 Reasons Johnson & Johnson Could Be the Perfect Stock to Own in Today's Turbulent Market (Motley Fool)
04:07AM	This Super-Safe High-Yield Stock Just Extended Its Dividend Growth Streak to 63 Years in a Row (Motley Fool)
Apr-16-25 06:35PM	Buy These Defensive Stocks After Beating Earnings Expectations?: ACI, JNJ (Zacks)
04:28PM	Analyst Report: Johnson & Johnson (Morningstar Research)
04:28PM	Johnson & Johnson to Participate in the 2025 RBC Capital Markets Global Healthcare Conference (Business Wire)
02:41PM	IYH: Healthcare Dashboard For April (Seeking Alpha)
12:28PM	J&Js electrophysiology sales dip amid slow Varipulse start (MedTech Dive)
11:59AM	Big banks report Q1 beats, China stops taking Boeing deliveries: Morning Buzz (TipRanks)
11:24AM	Needham upgrades Boston Scientific on easing competition, growth opportunities (Investing.com)
11:19AM	Is Johnson & Johnson (JNJ) the Best Dividend Monarch to Invest in Now? (Insider Monkey)
10:00AM	ETFs in Focus Post JNJ's Q1 Earnings Beat, Dividend Hike (Zacks)
09:31AM	Jim Cramer: Johnson & Johnson (JNJ) Is a "Great American Company with a AAA Balance Sheet" (Insider Monkey)
07:58AM	Johnson & Johnson Earnings Were More Good Than Bad-Time to Buy? (MarketBeat)
03:00AM	Johnson & Johnson (JNJ) Q1 2025 Earnings Call Highlights: Strong Sales Growth Amid STELARA ... (GuruFocus.com)
01:26AM	Q1 2025 Johnson & Johnson Earnings Call (Thomson Reuters StreetEvents)
Apr-15-25 10:15PM	Zeroes Across The Board (Seeking Alpha)
04:44PM	Stocks fizzle after two-day rally driven by bank earnings and tech (Quartz)
04:42PM	These Stocks Moved the Most Today: Bank of America, Citigroup, Netflix, Boeing, Tesla, HPE, Applied Digital, and More (Barrons.com)
03:49PM	J&J expects a $400M hit from tariffs, mostly from China (Yahoo Finance Video)
03:26PM	J&J Forecasts $400 Million in Tariff-Related Costs This Year (The Wall Street Journal)

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Decker Robert J	VP Corporate Controller	Feb 25 '25	Option Exercise	101.87	6,999	712,988	28,000	Feb 26 06:42 PM
Decker Robert J	VP Corporate Controller	Feb 25 '25	Sale	165.88	6,999	1,160,994	21,001	Feb 26 06:42 PM
Decker Robert J	Officer	Feb 25 '25	Proposed Sale	165.88	6,999	1,161,010		Feb 25 03:05 PM
Schmid Timothy	EVP, WW Chair, MedTech	Feb 14 '25	Option Exercise	0.00	2,806	0	17,904	Feb 18 09:46 PM
Schmid Timothy	EVP, WW Chair, MedTech	Feb 15 '25	Option Exercise	0.00	1,029	0	15,501	Feb 18 09:33 PM
Schmid Timothy	EVP, WW Chair, MedTech	Feb 14 '25	Option Exercise	0.00	1,765	0	15,111	Feb 18 09:33 PM
Schmid Timothy	EVP, WW Chair, MedTech	Feb 13 '25	Option Exercise	0.00	499	0	13,539	Feb 18 09:33 PM
Schmid Timothy	EVP, WW Chair, MedTech	Feb 18 '25	Sale	156.15	403	62,928	15,098	Feb 18 09:33 PM
Wengel Kathryn E	EVP, Chief TO and Risk Officer	Feb 15 '25	Option Exercise	0.00	607	0	91,037	Feb 18 09:16 PM
Wengel Kathryn E	EVP, Chief TO and Risk Officer	Feb 14 '25	Option Exercise	0.00	7,367	0	96,674	Feb 18 09:16 PM
Wengel Kathryn E	EVP, Chief TO and Risk Officer	Feb 13 '25	Option Exercise	0.00	651	0	89,603	Feb 18 09:16 PM
Wolk Joseph J	Exec VP, CFO	Feb 15 '25	Option Exercise	0.00	1,971	0	6,113	Feb 18 09:13 PM
Wolk Joseph J	Exec VP, CFO	Feb 14 '25	Option Exercise	0.00	19,330	0	20,661	Feb 18 09:13 PM
Wolk Joseph J	Exec VP, CFO	Feb 13 '25	Option Exercise	0.00	1,779	0	1,779	Feb 18 09:13 PM
REED JOHN C	EVP, Innovative Medicine, R&D	Feb 15 '25	Option Exercise	0.00	1,350	0	15,927	Feb 18 09:11 PM
Taubert Jennifer L	EVP, WWC. Innovative Medicine	Feb 15 '25	Option Exercise	0.00	1,594	0	171,110	Feb 18 09:08 PM
Taubert Jennifer L	EVP, WWC. Innovative Medicine	Feb 14 '25	Option Exercise	0.00	19,518	0	185,924	Feb 18 09:08 PM
Taubert Jennifer L	EVP, WWC. Innovative Medicine	Feb 13 '25	Option Exercise	0.00	1,302	0	167,221	Feb 18 09:08 PM
Swanson James D.	EVP, CIO	Feb 15 '25	Option Exercise	0.00	492	0	16,762	Feb 18 09:06 PM
Swanson James D.	EVP, CIO	Feb 14 '25	Option Exercise	0.00	5,079	0	19,739	Feb 18 09:06 PM
Swanson James D.	EVP, CIO	Feb 13 '25	Option Exercise	0.00	447	0	15,019	Feb 18 09:06 PM
Mulholland Kristen	EVP, Chief HR Officer	Feb 15 '25	Option Exercise	0.00	419	0	13,095	Feb 18 09:05 PM
Mulholland Kristen	EVP, Chief HR Officer	Feb 14 '25	Option Exercise	0.00	2,608	0	14,576	Feb 18 09:05 PM
Mulholland Kristen	EVP, Chief HR Officer	Feb 13 '25	Option Exercise	0.00	411	0	12,100	Feb 18 09:05 PM
Forminard Elizabeth	Executive VP, General Counsel	Feb 15 '25	Option Exercise	0.00	961	0	10,321	Feb 18 09:03 PM
Forminard Elizabeth	Executive VP, General Counsel	Feb 14 '25	Option Exercise	0.00	2,203	0	11,366	Feb 18 09:03 PM
Forminard Elizabeth	Executive VP, General Counsel	Feb 13 '25	Option Exercise	0.00	651	0	8,991	Feb 18 09:03 PM
Duato Joaquin	CEO and Chairman of the Board	Feb 15 '25	Option Exercise	0.00	3,682	0	397,525	Feb 18 09:02 PM
Duato Joaquin	CEO and Chairman of the Board	Feb 14 '25	Option Exercise	0.00	24,335	0	415,205	Feb 18 09:02 PM
Duato Joaquin	CEO and Chairman of the Board	Feb 13 '25	Option Exercise	0.00	3,470	0	392,498	Feb 18 09:02 PM
Decker Robert J	VP Corporate Controller	Feb 15 '25	Option Exercise	0.00	339	0	20,116	Feb 18 09:01 PM
Decker Robert J	VP Corporate Controller	Feb 14 '25	Option Exercise	0.00	2,201	0	21,373	Feb 18 09:01 PM
Decker Robert J	VP Corporate Controller	Feb 13 '25	Option Exercise	0.00	312	0	19,285	Feb 18 09:01 PM
Broadhurst Vanessa	EVP, Global Corp Affairs	Feb 15 '25	Option Exercise	0.00	492	0	21,839	Feb 18 08:58 PM
Broadhurst Vanessa	EVP, Global Corp Affairs	Feb 14 '25	Option Exercise	0.00	4,740	0	24,591	Feb 18 08:58 PM
Broadhurst Vanessa	EVP, Global Corp Affairs	Feb 13 '25	Option Exercise	0.00	408	0	20,242	Feb 18 08:58 PM
Duato Joaquin	CEO and Chairman of the Board	Feb 07 '25	Option Exercise	100.06	126,369	12,644,482	489,671	Feb 11 07:43 PM
Wengel Kathryn E	EVP, Chief TO and Risk Officer	Feb 07 '25	Option Exercise	100.06	32,762	3,278,166	115,028	Feb 11 07:42 PM
Taubert Jennifer L	EVP, WWC. Innovative Medicine	Feb 07 '25	Option Exercise	100.06	58,504	5,853,910	213,355	Feb 11 07:41 PM
Wolk Joseph J	Exec VP, CFO	Feb 07 '25	Option Exercise	100.06	13,015	1,302,281	13,015	Feb 11 07:40 PM
Wolk Joseph J	Exec VP, CFO	Feb 07 '25	Sale	153.89	13,015	2,002,878	0	Feb 11 07:40 PM
Wolk Joseph J	Officer	Feb 07 '25	Proposed Sale	153.89	13,015	2,002,924		Feb 07 01:27 PM
WEINBERGER MARK A	Director	Dec 12 '24	Buy	147.22	1,000	147,220	1,000	Dec 12 05:27 PM
Hait William	Former Officer	Dec 04 '24	Proposed Sale	149.90	25,742	3,858,598		Dec 04 01:25 PM
Decker Robert J	VP Corporate Controller	Aug 30 '24	Option Exercise	100.06	5,635	563,838	24,608	Sep 03 04:48 PM
Decker Robert J	VP Corporate Controller	Aug 30 '24	Sale	165.06	5,635	930,113	18,973	Sep 03 04:48 PM
Decker Robert J	Officer	Aug 30 '24	Proposed Sale	165.06	5,635	930,113		Aug 30 03:51 PM
Broadhurst Vanessa	EVP, Global Corp Affairs	Jul 08 '24	Option Exercise	0.00	9,809	0	24,852	Jul 09 05:48 PM
REED JOHN C	EVP, Innovative Medicine, R&D	May 01 '24	Option Exercise	0.00	22,255	0	22,561	May 03 04:31 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

JNJ

Johnson & Johnson

Upgrade your FINVIZ experience